Moses Cesario

Moses Cesario has a diverse work experience in various industries. Moses is currently the CEO of Butterfly Biosciences, Inc., where they are focused on providing affordable and non-surgical fertility care options. Prior to this role, Moses served as the Operations Director, Investor, and Board Member at World Top Docs, Inc., where they aimed to extend high-quality healthcare to individuals worldwide. Moses also worked as a Consulting COO at Microgenesis Corporation and as a Consulting CEO at Mediphage Bioceuticals Inc. Furthermore, Moses has experience as the CEO and President of Previvo Genetics, Inc., where they developed a proprietary device for fertility preservation and genetic disease screening. Earlier in their career, they held executive positions at Ramsell Corporation, Affymetrix, Neomorphic, Inc., AT&T, and Wells Fargo.

Moses Cesario has a diverse education history. Moses obtained a Bachelor of Arts degree in English/Biology/Genetics from the University of California, Berkeley from 1987 to 1991. In 2004, Moses attended the Stanford University Graduate School of Business and completed the SEP (Stanford Executive Program). Later, they pursued further education and earned a Master of Science degree in Computer Science from Golden Gate University between 2005 and 2007. Moses also obtained a certification in Business Administration from Stanford University in June 2004.